Literature DB >> 11360244

Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein.

J Z Zhang1, M H Ng, N S Xia, S H Lau, X Y Che, T N Chau, S T Lai, S W Im.   

Abstract

A 23 kDa peptide locating to amino acid residues 394 to 604 of the major Hepatitis E Virus (HEV) structural protein was expressed in E. coli. This peptide was found to interact naturally with one another to form homodimers and it was recognized strongly and commonly in its dimeric form by HEV reactive human sera. The antigenic activity associated with the dimeric form was abrogated when the dimer was dissociated into monomer and the activity was reconstituted after the monomer was re-associated into dimer again. The dimeric form of the peptide elicited a vigorous antibody response in experimental animals and the resulting antisera were found to cross-react against HEV, effecting an efficient immune capture of the virus. These results attributed the antigenic activity associated with the dimeric form of the peptide to conformational antigenic determinants generated as a result of interaction between the peptide molecules. It is suggested that some of these antigenic determinants may be expressed by the HEV capsid and raised the possibility of this bacterially expressed peptide as an HEV vaccine candidate. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360244     DOI: 10.1002/jmv.1027

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology.

Authors:  Ying Gu; Jun Zhang; Ying-Bing Wang; Shao-Wei Li; Hai-Jie Yang; Wen-Xin Luo; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 2.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Hepatitis E vaccine.

Authors:  Rakesh Aggarwal; Shahid Jameel
Journal:  Hepatol Int       Date:  2008-04-10       Impact factor: 6.047

4.  Significance of serum IgA in patients with acute hepatitis E virus infection.

Authors:  De-Ying Tian; Yan Chen; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 5.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 6.  Diagnosis of hepatitis E.

Authors:  Rakesh Aggarwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

7.  Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction.

Authors:  Shaowei Li; Xuhua Tang; J Seetharaman; Chunyan Yang; Ying Gu; Jun Zhang; Hailian Du; J Wai Kuo Shih; Choy-Leong Hew; J Sivaraman; Ningshao Xia
Journal:  PLoS Pathog       Date:  2009-08-07       Impact factor: 6.823

8.  Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts.

Authors:  Chunyan Yang; Huirong Pan; Minxi Wei; Xiao Zhang; Nan Wang; Ying Gu; Hailian Du; Jun Zhang; Shaowei Li; Ningshao Xia
Journal:  Protein Sci       Date:  2013-01-17       Impact factor: 6.725

Review 9.  Hepatitis E virus: Current epidemiology and vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Xiaotian Hao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

10.  A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice.

Authors:  Yuan-Xiang Zhou; Maggie Yuk-Ting Lee; James Ming-Him Ng; Mee-Len Chye; Wing-Kin Yip; Sze-Yong Zee; Eric Lam
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.